Adequate bone marrow, cardiac, kidney and liver function
Adequate bone marrow, kidney, and liver function
Prior SOT of kidney, liver, heart, lung, pancreas, small bowel, or any combination of these
Adequate bone marrow, kidney and liver function
Adequate bone marrow, kidney and liver function
Adequate bone marrow, liver and kidney function
Participants have adequate bone marrow, kidney and liver function.
Adequate performance status and hematological, liver, and kidney function
Adequate bone marrow, kidney and liver function
Good kidney and liver function
Adequate bone marrow, cardiac, kidney and liver function
Severe impairment of your kidney or liver function
Patients must have adequate bone marrow, kidney, and liver function, (within 14 days prior to registration), defined as:
Must have adequate coagulation, hematology, kidney, and liver function, per protocol.
Patient with bilateral LG UTUC may be enrolled if at least one side meets the inclusion criteria for the trial and if the other kidney does not require further treatments (The other kidney can be treated prior to the beginning of the study).
Good kidney and liver function
Normal liver, kidney and bone marrow function
Must have adequate hepatic and kidney function.
Adequate bone marrow, liver and kidney function
Kidney function: creatinine < 2.5 x ULN.
History of severe kidney disease (e.g chronic or acute kidney failure) with creatinine clearance below 30 and/or severe liver disease with liver tests over 4 times the upper normal level
Patient with only 1 kidney
History of kidney stones
In cases of concern about decreased renal function and potential high radiation dose to the kidneys, an optional nuclear medicine kidney function scan may be performed prior to radiation therapy to determine the functional contribution of each kidney
Significant liver, lung, heart, or kidney dysfunction
Adequate hematological, liver and kidney function.
Adequate hematological, liver, and kidney function
Chronic kidney disease > stage 3.
Adequate bone marrow, liver, kidney function
Adequate bone marrow, kidney, and hepatic function (no laboratory value > 2 times the normal limit)
Adequate bone marrow, kidney and liver function
Patients must have adequate heart, kidney, liver and bone marrow function.
Subject must have adequate kidney and liver function as described in the protocol
Abnormal kidney function test results
Adequate major organ function (normal or minimal alteration in liver, kidney, hematological, metabolic and cardiac function)
Adequate hematological, liver and kidney function.
Adequate hematologic, liver, coagulation and kidney function
Adequate bone marrow, kidney and liver function
Adequate liver, kidney, and bone marrow function
Adequate bone marrow, kidney and liver function.
Performance Status of 0 or 1 - Adequate bone marrow, kidney and liver function
Active severe kidney or liver disease
Adequate organ function (bone marrow, kidney and liver)
Adequate kidney function
Adequate liver, kidney, and bone marrow function
Participants must have adequate liver, kidney, and bone morrow function
Adequate hematological, liver and kidney function.
Adequate glucose control, bone marrow, kidney, liver, and heart function.
Patients with a solitary kidney
Adequate bone marrow, kidney and liver function
Severe impairment of your kidney or liver function
Adequate bone marrow, kidney, liver, and heart function.
Adequate blood, liver, and kidney function as defined by laboratory tests.
Subjects must have adequate kidney function
Adequate hematologic, kidney and liver function
Adequate bone morrow and kidney function
Adequate bone marrow, kidney and liver function
Acceptable bone marrow, liver and kidney function.
Adequate bone marrow, kidney, and liver function
Inadequate functions of bone marrow, liver, and kidney.
Has adequate organ function (bone marrow, kidney and liver)
Have adequate cardiac, bone marrow, liver and kidney function
Participants must have adequate hepatic and kidney function.
Patients must have acceptable neutrophil and platelet counts as well as adequate kidney and liver function.
Patients with recent history of kidney stones.
Kidney tumor has been removed
Adequate hematologic and organ function, including blood counts, liver and kidney function Stage I Arm A (GDC-0077):
Normal kidney and liver function (lab results must be within 45 days prior enrollment)
Solitary kidney
No active kidney stones
Chronic kidney disease or in participants without known kidney disease, estimated creatinine clearance of =< 30 ml/min, even after rehydration
Any history of cardiovascular, kidney, or liver disease
acute kidney injury
Adequate bone marrow, liver and kidney function
History of severe kidney disease (e.g. chronic or acute kidney failure) with creatinine clearance below 30 and/or severe liver disease with liver tests over 4 times the upper normal level
Underlying kidney disease with a high risk of disease recurrence in the transplanted kidney
Known chronic kidney disease (creatinine >= 3.0)
Adequate hematological, liver and kidney function.
Adequate bone marrow reserves and liver and kidney function, as assessed by the following laboratory requirements:
Have adequate bone marrow reserves and liver and kidney function, as assessed by the following laboratory requirements:
Have known history of kidney diseases
Patients who have chronic kidney disease
Renal (kidney) disease, or solitary kidney
or have a history of kidney disease.
Adequate performance status and hematological, liver, and kidney function
Good kidney and liver function
Adequate bone marrow, liver, and kidney function within 2 weeks prior to first dose
Adequate function of kidney:
Adequate bone marrow, kidney and liver function
